Guo&Amp;'s Distal Entry Tear Repair With WeFlow-EndoPatch System (Gallant Study)

Exclusion Criteria

• •Rupture or threatened rupture of aortic dissection;
• •Proximal type I internal leakage after aortic repair;
• •New distal SINE;
• •Abdominal aortic dissection aneurysm diameter ≥5 cm;
• •The edge of the tear from the opening of celiac trunk is\<4 mm;
• •The same operation requires intervention in other vascular diseases (such as coronary artery, renal artery, superior mesenteric artery, etc.);
• •Acute systemic infection;
• •History of myocardial infarction, TIA or cerebral infarction within the past 3 months;
• •Cardiac function Grade IV (NYHA rating) or LVEF \&lt; 30%;
• •Hematological abnormalities: leukopenia (WBC \&lt; 3×10\^9/L), anemia (Hb \&lt; 90 g/L); Coagulation dysfunction, thrombocytopenia (PLT count \&lt; 50×10\^9/L);
• •Renal insufficiency: serum creatinine \&gt; 150 umol/L (or 3.0 mg/dL) and/or advanced kidney disease requiring renal dialysis, as determined by the investigator after thorough analysis;
• •Severe liver insufficiency: alanine aminotransferase (ALT) or aspartate aminotransferase (AST) exceeds the normal upper limit by 5 times; Serum total bilirubin (STB) exceeded the normal upper limit by 2 times;
• •Allergic to contrast agents, anesthetics, patchs, and delivery materials;
• •Pregnant or breastfeeding;
• •Participated in clinical trials of other drugs or devices during the same period;
• •Life expectancy is less than 12 months (such as advanced malignant tumors); Investigator judged that not suitable for interventional treatment.